STERIS plc (STE) reported third-quarter 2026 results with total revenue of $1.46 billion, up 6.55% year-over-year. The company posted improvements across profitability metrics, including gross profit of $645.9 million (+5.83% YoY) and operating profit of $265.8 million (+8.36% YoY). Net income attributable to common shareholders rose to $191.9 million (+10.58% YoY), and diluted earnings per share came in at $1.94 (+10.86% YoY).
On the cash-flow and balance-sheet front, operating cash flow declined year-over-year while liquidity improved. Cash from operating activities was $298.2 million (down 10.4% YoY), and the company invested $98.7 million in property, plant and equipment. Cash and cash equivalents rose to $319.2 million (up 105.7% YoY), while total liabilities fell to $3.39 billion (down 5.35% YoY).
Results compared with analyst expectations showed revenue and EPS below estimates. Consensus revenue was about $1.50 billion, and the EPS estimate was roughly $2.56; the stock reacted with a decline of 2.48% since market close.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
STERIS plc Insider Trading Activity
STERIS plc insiders have traded $STE stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $STE stock by insiders over the last 6 months:
- JOHN ADAM ZANGERLE (Sr. VP, Gen Counsel, and Sec.) sold 15,000 shares for an estimated $3,977,100
- RENATO TAMARO (V.P. & Corporate Treasurer) has made 0 purchases and 4 sales selling 8,240 shares for an estimated $2,095,604.
- KAREN L BURTON (VP & CAO) sold 7,900 shares for an estimated $1,909,667
- JULIA MADSEN (Sr. VP and GM, Life Sciences) has made 0 purchases and 2 sales selling 5,008 shares for an estimated $1,312,096.
- MOHSEN SOHI sold 4,110 shares for an estimated $994,455
- CYNTHIA L FELDMANN sold 3,495 shares for an estimated $844,252
- DANIEL A CARESTIO (President and CEO) sold 159 shares for an estimated $38,449
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
STERIS plc Hedge Fund Activity
We have seen 432 institutional investors add shares of STERIS plc stock to their portfolio, and 396 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,049,053 shares (+75.7%) to their portfolio in Q3 2025, for an estimated $259,577,674
- WCM INVESTMENT MANAGEMENT, LLC removed 927,121 shares (-44.2%) from their portfolio in Q3 2025, for an estimated $229,406,820
- AQR CAPITAL MANAGEMENT LLC added 758,423 shares (+178.6%) to their portfolio in Q3 2025, for an estimated $187,664,187
- BOSTON PARTNERS added 642,539 shares (+inf%) to their portfolio in Q3 2025, for an estimated $158,989,850
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 627,817 shares (-13.0%) from their portfolio in Q4 2025, for an estimated $159,164,165
- THRIVENT FINANCIAL FOR LUTHERANS added 550,191 shares (+15102.7%) to their portfolio in Q3 2025, for an estimated $136,139,261
- POINT72 ASSET MANAGEMENT, L.P. removed 423,327 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $104,748,032
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
STERIS plc Congressional Stock Trading
Members of Congress have traded $STE stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $STE stock by members of Congress over the last 6 months:
- REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 2 times. They made 2 purchases worth up to $30,000 on 09/18, 09/11 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.